Anhui Lianchuang Biological Medicine Co.,Ltd

more> Company Profile

Anhui Lianchuang Biopharmaceutical Co., Ltd. was established in 2009 . Headquartered in the west section of Fenghua Avenue, Hefei Economic and Technological Development Zone. It is a national high-tech enterprise with the mission of serving health and pursuing technological contributions. An innovative technology company providing products and technical services to global pharmaceutical and chemical manufacturers.

more> News

2023-04-18Courier | abbvie announced JAK inhibitor "deuba substitute, approved in the eu" in the treatment of crohn's disease
2023-03-25Courier | abbvie JAK inhibitor treatment of lupus erythematosus (sle) positive results, entering the phase 3 clinical trials
2023-02-15Courier | treatment last year! Phase 2 trials of oral JAK inhibitors were positive and effective in treating this type of skin disease
2023-01-30Key frontier | found knee pain treatment! STAT3 makes chondrocytes young again
2022-12-12Courier | significantly lower blood sugar level, diabetes therapy phase 3 of the primary end point
2022-12-07SGLT-2 inhibitors: from hypoglycemic to improved cardiac, cerebral and renal clinical outcomes
2022-11-07Courier | significantly slow kidney disease progression and cardiovascular death! The blockbuster SGLT2 inhibitor reached phase 3 clinical endpoint
2022-10-31Courier | targeted STAT3 treatment of hepatocellular carcinoma (HCC), innovative therapy for the FDA to fast-track qualification?
2022-10-26Phase 3 clinical success of new drugs for diabetes mellitus
2022-10-26The second imported compound antidiabetic drug is coming in 2017

more> Contact Us

Tel：+8655168596228
Fax：+8655168596338
Email：sales@lcywhx.com

more> Product

ABOUT US

PRODUCT